• Profile
Integrating Immunotherapy into Early-Stage Lung Cancer
Date: Fri 29 Dec, 2023 8:00–9:00pm
Duration: 1 hour


What the session is about

Discussion (8:00 to 8:45 pm)

  • Treatment for stages 1 to 3A
  • Induction chemotherapy 
  • Surgery with adjuvant chemotherapy or radiotherapy 
  • Immune checkpoint inhibitors in early-stage NSCLC 
  • Usage of inhibitors in early NSCLC

Interactive Q&A (8:45 to 9:00 pm)

  • Register now and send your questions through the chat window
  • You can also send questions 'Live' during the Webinar on December 29th through the chat window below the video
About the presenter:
Dr shyam agarwal picture 1703143219

Dr. Shyam Aggarwal (Chairman and head of the Department of Medical Oncology at Sir Ganga Ram Hospital, New Delhi)

  • He completed his MBBS and M.D. in Internal Medicine, achieving a Silver Medal.
  • He has been awarded the NIH-International Fogarty Fellowship for training in the field of bone marrow, transplantation and basic medical research at UCLA. Los Angeles, USA
  • He is an editor of a few Journals & one of the advisory Board members in Merck Pharmaceuticals, Roche Pharmaceuticals, J & J Pharmaceuticals, AstraZeneca Pharmaceuticals, and Intas Pharmaceuticals
  • He is been a member of multiple Educational and Medical Organisations for example ASCO, EHA, ISMPO, ISO, and APOCP
  • He is been a co-author of several paper publications, the recent one is the Clinical Plasma Metabolite Panel correlating with Response to Anti PD-1 Therapy in Patients with Advanced Lung Cancer in April 2023 and Submitted to frontiers in molecular biosciences
  • There are around 22 international conferences & educational activities organised under the doctor's supervision
  • He has been a principal investigator in numerous Clinical Trials
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen